Kerala Ayurveda Reports 22% Revenue Growth in FY25

Kerala Ayurveda Ltd announces consolidated revenues of ₹137.2 crore for the year ended March 31, 2025, registering 22% YoY growth. The company incurred a positive adjusted EBITDA of ₹3.1 crore, despite amplified investment in its digital, healthcare, and international expansion categories. But its net loss widened to ₹13.95 crore in FY24, as operating and strategic development costs shot up from ₹56 lakh.

Key Financial Highlights (Consolidated)

Investments during FY25 included ₹6 crore in capex, ₹13.5 crore in talent acquisition, ₹6 crore in digital marketing, and ₹6.2 crore in ESOP provisioning.

Management Commentary

KAL emphasized its long-term commitment to building a sustainable, global Ayurveda business through disciplined investments. The management highlighted its FY26 goal to “combine products, services, and education into a digitally powered Ayurveda ecosystem.”

About Kerala Ayurveda

Founded 80 years ago, Kerala Ayurveda Ltd is among the oldest full-spectrum listed Ayurveda companies globally. It operates across India and the USA, offering over 400 products and serving more than 100,000 patients annually. Its US-based Academy has certified over 3,500 graduates with 6,000+ hours of certified programs.

With a strong foundation laid in FY25, KAL’s renewed growth momentum, supported by international alliances and digital-first strategies, positions it as a formidable player in the global holistic wellness industry.

Disclaimer: This content is only for informational purpose. It does not make any recommendation to act or invest. The content is based on highly reliable resources. Still if there is any error it is deeply regretted. Write to us for getting any error corrected.

REF: https://www.bseindia.com/xml-data/corpfiling/AttachLive/eac08ad5-c701-480b-91da-b641dc262774.pdf